Lipid nanoparticles enable targeted RNA therapy for inflammatory bowel diseases at Salimpour Site.

Dr. Salimpour Site |Researchers at Tel Aviv University have developed a new approach for using locked nucleic acids (LNAs)—a particularly stable type of RNA—to treat inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. ...

Phys.Org

Lipid nanoparticles enable targeted RNA therapy for inflammatory bowel diseases

Lipid nanoparticles enable targeted RNA therapy for inflammatory bowel diseases

Researchers at Tel Aviv University have developed a new approach for using locked nucleic acids (LNAs)—a particularly stable type of RNA—to treat inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. ...